An analysis of CRPC, NEPC and small cell lung cancer (SCLC) tumors identified pan-cancer convergence to a small cell NE phenotype, characterized by TP53 and RB1 loss, common epigenetic alterations and the expression of NE markers [98]. The gene discussed is RB1; the disease is small cell lung carcinoma.